Apex Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $38M | Buy |
1,292,751
+82,294
| +7% | +$2.42M | 0.84% | 54 |
|
|
2015
Q4 | $40M | Sell |
1,210,457
-10,858
| -0.9% | -$359K | 0.89% | 47 |
|
|
2015
Q3 | $44.1M | Buy |
1,221,315
+61,874
| +5% | +$2.24M | 1% | 39 |
|
|
2015
Q2 | $52.2M | Buy |
1,159,441
+56,318
| +5% | +$2.53M | 1.12% | 36 |
|
|
2015
Q1 | $33.8M | Buy |
1,103,123
+516,422
| +88% | +$15.8M | 0.8% | 53 |
|
|
2014
Q4 | $29.8M | Buy |
586,701
+536,451
| +1,068% | +$27.3M | 0.8% | 52 |
|
|
2014
Q3 | $1.99M | Buy |
50,250
+5,157
| +11% | +$204K | 0.06% | 172 |
|
|
2014
Q2 | $1.94M | Buy |
45,093
+6,338
| +16% | +$273K | 0.06% | 174 |
|
|
2014
Q1 | $1.55M | Buy |
+38,755
| New | +$1.55M | 0.05% | 176 |
|